Hepatic yttrium-90 radioembolization for metastatic melanoma: a single-center experience.

@article{Memon2014HepaticYR,
  title={Hepatic yttrium-90 radioembolization for metastatic melanoma: a single-center experience.},
  author={Khairuddin Memon and Timothy Michael Kuzel and Michael Vouche and Rohi Atassi and Robert J. Lewandowski and Riad Salem},
  journal={Melanoma research},
  year={2014},
  volume={24 3},
  pages={
          244-51
        }
}
The aim of the study was to analyze the safety and efficacy of yttrium-90 ((90)Y) radioembolization in the treatment of unresectable hepatic melanoma metastases refractory to previous systemic/locoregional therapy. Between February 2004 and April 2010, 16 patients with hepatic melanoma metastases (ocular=7, skin=4, other sites=5) were treated with (90)Y radioembolization at a single center. Toxicity was assessed using the National Cancer Institute Common Terminology Criteria, version 3.0… CONTINUE READING
View on PubMed